Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Li-FT Power (LIFT) has commenced its first diamond drill program at the Rupert Lithium Project in James Bay, Quebec
  • 17 holes have been planned over 5,000 m of diamond drilling to test robust lithium anomalies
  • Li-FT is engaged in the acquisition, exploration, and development of mineral properties, specifically lithium pegmatite projects
  • Li-FT Power (LIFT) is up by 2.93 per cent trading at $8.44 per share

Li-FT Power (LIFT) has commenced its first diamond drill program at the Rupert Lithium Project in James Bay, Quebec.

Target A is located 3 km to the northwest of Target B at the head of a 3 km-long Li-in-tills dispersion train. The company has planned eight exploration holes totaling 2,500 m across the target.

Nine drill holes are planned at Target B for a total of 2,500 m. Holes are planned to cross the head of a 1 km-long, Li-in-tills dispersion train where the head terminates abruptly against a structure in a WNW direction.

“We have systematically explored approximately 2,000 square kilometers of prospective geology that hosts the Whabouchi Lithium Deposit (37.4 million tons at 1.48 per cent Li2O1) and have generated nine high-quality targets for follow-up exploration,” stated Francis MacDonald, CEO of Li-FT.

“Our first drill program will target two robust lithium anomalies at Target A and B in the right geological setting proximal to a large granite intrusion. These anomalies are large enough to represent a significant spodumene occurrence in one of the most exciting lithium pegmatite districts on the planet,” he added.

Li-FT is engaged in the acquisition, exploration, and development of mineral properties, specifically lithium pegmatite projects.

Li-FT Power (LIFT) is up by 2.93 per cent trading at $8.44 per share as of 11:13 am EST.

For full disclaimer information, please click here.


More From The Market Herald
Neuralink - Founder, Elon Musk.

" Neuralink brain chips approved for human trials

Elon Musk’s Neuralink, a brain implant firm, has received regulatory approval for U.S. human trials.

" @ the Bell: TSX snaps three-day losing skid

After a series of sessions in the red, Canada’s main stock index closed out Friday trading in the green as commodity prices nudged

" Marvell stock spikes 30 per cent on Q1 news  

Marvell Technology (NASDAQ:MRVL) shares rose more than 30 per cent Friday.